Onyx Biotec Limited (NSE:ONYX)
36.00
-0.10 (-0.28%)
At close: Sep 24, 2026
Onyx Biotec Market Cap
Onyx Biotec has a market cap or net worth of 652.76 million as of September 25, 2026. Its market cap has decreased by -21.40% in one year.
Market Cap
652.76M
Enterprise Value
764.10M
Revenue
694.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.00
ChartMarket Cap Chart
Since November 22, 2024, Onyx Biotec's market cap has decreased from 1.03B to 652.76M, a decrease of -36.56%. That is a compound annual growth rate of -21.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 652.76M | -11.76% |
| Dec 31, 2025 | 739.79M | -54.46% |
| Dec 31, 2024 | 1.62B | 57.89% |
| Nov 22, 2024 | 1.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Denis Chem Lab | 962.76M |
| Parmax Pharma | 938.28M |
| Amwill Health Care | 860.15M |
| Source Natural Foods and Herbal Supplements | 701.30M |
| Shelter Pharma | 627.17M |
| Phaarmasia | 611.35M |
| Cian Healthcare | 565.50M |
| Rekvina Laboratories | 554.68M |